Novo Nordisk News | Latest News - 쮸떴눈첵

Novo Nordisk

In the last 4 hours

TipRanks05:23

Sifted05:11

In the last 8 hours

Yahoo! UK & Ireland01:17

Yesterday

Business Wire (Press Release)10:27 23-Apr-25

The Times of India06:33 23-Apr-25

The Motley Fool05:50 23-Apr-25

The Motley Fool05:09 23-Apr-25

Business Plus Online04:18 23-Apr-25

GlobeNewswire (Press Release)03:01 23-Apr-25

In the last 7 days

This is Money17:17 22-Apr-25

The Times of India15:05 22-Apr-25

The Motley Fool12:20 22-Apr-25

Gizmodo12:14 22-Apr-25

The Hindu Business Line11:52 22-Apr-25

Macau Business10:43 22-Apr-25

FiercePharma09:03 22-Apr-25

Sifted08:57 22-Apr-25

The Motley Fool08:47 22-Apr-25

Yahoo! UK & Ireland06:11 22-Apr-25

Fortune05:14 22-Apr-25

The Economic Times04:12 22-Apr-25

Invezz02:53 22-Apr-25

The Times of India02:34 22-Apr-25

Motley Fool (UK)01:39 22-Apr-25

Zacks18:53 21-Apr-25

Scrip Pharma Intelligence15:47 21-Apr-25

Green Queen11:35 21-Apr-25

Zacks10:05 21-Apr-25

The Motley Fool09:23 21-Apr-25

Scientific American08:49 21-Apr-25

The Motley Fool04:38 21-Apr-25

Gulf Times17:28 20-Apr-25

TipRanks10:04 19-Apr-25

The Motley Fool03:28 19-Apr-25

The Economic Times20:11 18-Apr-25

Nasdaq16:11 18-Apr-25

Futurism15:03 18-Apr-25

Pharmacy Times13:35 18-Apr-25

Power Corridor06:32 18-Apr-25

The Irish Times04:23 18-Apr-25

Benzinga22:30 17-Apr-25

Law36022:16 17-Apr-25

Hindustan Times21:26 17-Apr-25

FiercePharma16:39 17-Apr-25

Benzinga15:36 17-Apr-25

Yahoo! US14:50 17-Apr-25

The Motley Fool12:47 17-Apr-25

Forbes10:53 17-Apr-25

Yahoo! UK & Ireland10:33 17-Apr-25

London South East08:48 17-Apr-25

NBC Connecticut08:13 17-Apr-25

Korea Biomedical Review01:03 17-Apr-25

In the last month

Fox News17:55 16-Apr-25

NPR16:07 16-Apr-25

Vice (US)15:02 16-Apr-25

Pharmaceutical Technology11:18 16-Apr-25

The Kansas City Star01:00 16-Apr-25

KCBD, Texas23:23 15-Apr-25

KCRG TV 9, Iowa22:26 15-Apr-25

Law36021:04 15-Apr-25

ABC7 / WLS-TV21:02 15-Apr-25

PR Newswire (Press Release)17:22 15-Apr-25

Benzinga16:31 15-Apr-25

Black Enterprise16:03 15-Apr-25

Benzinga15:20 15-Apr-25

Zacks11:03 15-Apr-25

The Motley Fool10:23 15-Apr-25

Business Wire (Press Release)09:01 15-Apr-25

Business Wire (Press Release)05:34 15-Apr-25

Northwest Arkansas Democrat-Gazette03:36 15-Apr-25

Bernama02:02 15-Apr-25

Campaign Brief23:41 14-Apr-25

WHDH-TV, Massachusetts22:09 14-Apr-25

NBC Connecticut20:38 14-Apr-25

B&T Marketing & Media19:48 14-Apr-25

Law36019:26 14-Apr-25

UPI18:47 14-Apr-25

Bloomberg Law12:59 14-Apr-25

Science|Business12:28 14-Apr-25

Investing.com UK11:50 14-Apr-25

PR Newswire (Press Release)11:49 14-Apr-25

The Motley Fool11:18 14-Apr-25

PR Newswire (Press Release)10:59 14-Apr-25

Yahoo! US10:52 14-Apr-25

The Economic Times10:19 14-Apr-25

AdNews10:09 14-Apr-25

Gulf News09:04 14-Apr-25

pharmaphorum08:19 14-Apr-25

Motley Fool (UK)02:33 13-Apr-25

The Economic Times20:45 11-Apr-25

Scrip Pharma Intelligence11:07 11-Apr-25

Zacks10:44 11-Apr-25

Korea Biomedical Review05:03 11-Apr-25

Law36021:47 10-Apr-25

FoodNavigator.com12:04 10-Apr-25

Science News Online11:03 10-Apr-25

Zacks06:03 10-Apr-25

Yahoo! UK & Ireland05:58 10-Apr-25

Zacks18:01 9-Apr-25

Pharmaceutical Online14:07 9-Apr-25

The Motley Fool10:03 9-Apr-25

Pharmaceutical Technology08:00 9-Apr-25

ENDPOINTS06:56 9-Apr-25

Morningstar06:44 9-Apr-25

Fortune06:41 9-Apr-25

Law36020:26 8-Apr-25

MorningStar.com19:34 8-Apr-25

Bloomberg Law19:08 8-Apr-25

Courthouse News14:15 8-Apr-25

The Economic Times12:46 8-Apr-25

Global Construction Review12:31 8-Apr-25

ENDPOINTS11:37 8-Apr-25

Zacks11:18 8-Apr-25

Zacks10:07 8-Apr-25

FiercePharma09:57 8-Apr-25

view more headlines

24 Apr 05:23

About our Novo Nordisk news

Latest news on Novo Nordisk, a global healthcare company focused on diabetes care, obesity treatment, and other serious chronic diseases. Get updates on Novo Nordisk's products, research, financial performance, and stock price.

Novo Nordisk is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark. Founded in 1923, the company has grown to become a global leader in diabetes care, with a strong presence in the fields of hemophilia, growth hormone therapy, and obesity treatment. Novo Nordisk's key products include insulin analogs like Tresiba and Levemir, GLP-1 receptor agonists such as Victoza and Ozempic, and obesity drugs like Saxenda and Wegovy.

Stay informed about the latest developments in Novo Nordisk's research and development pipeline, including updates on clinical trials, regulatory approvals, and new product launches. Our feed covers the company's ongoing efforts to innovate and improve treatments for diabetes, obesity, and other metabolic disorders, such as the development of oral semaglutide and the exploration of novel drug targets.

In addition to product news, our Novo Nordisk feed keeps you updated on the company's financial performance, including quarterly earnings reports, sales figures, and market share data. We also cover key events and announcements that may impact Novo Nordisk's stock price (NYSE: NVO), such as strategic partnerships, acquisitions, and leadership changes.

Beyond the business aspects, our feed highlights Novo Nordisk's commitment to corporate social responsibility and sustainability. From initiatives to improve access to diabetes care in developing countries to efforts to reduce the company's environmental footprint, we provide a comprehensive view of Novo Nordisk's impact on global health and society.

As the prevalence of diabetes and obesity continues to rise worldwide, Novo Nordisk plays a crucial role in addressing these global health challenges. Our 쮸떴눈첵 feed on Novo Nordisk brings you the most relevant and up-to-date information from reliable sources, helping you stay informed about this innovative and influential healthcare company.

쮸떴눈첵

Novo Nordisk

About our Novo Nordisk news

Pharmaceuticals Top Stories

Business Top Stories